No - not a spin job. Our CEO demonstrated good knowledge of the market place the business is addressing and is clearly interested in his work. He seems more energised by the work than burdened by it.
Slogger and I and many of you are never going to agree with many aspects of the how he runs the business - but I was not attempting to change his mind or sow seeds, so I steered well clear of these issues. Just on a respectful fact finding mission here.
It’s clear that the pharmaceutical business has much hidden complexity in its approvals, sales and supply chains. Perhaps something I was only vaguely aware of
Michael stated that the sp performance is unacceptable and did not try to explain or justify it. Not a great response but far better than trying to spin it as ok or all part of the plan. Some would try that - in other words some would try to say black is actually white and it is my fault for not realising it. By not doing that he treated me with decency.
I am not pretending that I found good tidings - I did not! But at least they are still trying.
- Forums
- ASX - By Stock
- Ann: Appendix 4D, Half Year Accounts as at 31 December 2021
ACR
acrux limited
Add to My Watchlist
0.00%
!
2.0¢

No - not a spin job. Our CEO demonstrated good knowledge of the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.155M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 1.9¢ | $13.65K | 683.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 571000 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 234041 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 571000 | 0.019 |
3 | 381800 | 0.018 |
3 | 472000 | 0.017 |
1 | 66732 | 0.015 |
1 | 70000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 234041 | 2 |
0.021 | 80630 | 1 |
0.022 | 204574 | 4 |
0.023 | 115126 | 4 |
0.024 | 306848 | 8 |
Last trade - 12.14pm 18/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online